Sei Investments Co. Grows Stock Position in CME Group Inc. (NASDAQ:CME)

Sei Investments Co. raised its holdings in CME Group Inc. (NASDAQ:CMEFree Report) by 3.2% in the 4th quarter, Holdings Channel reports. The institutional investor owned 244,361 shares of the financial services provider’s stock after acquiring an additional 7,506 shares during the period. Sei Investments Co.’s holdings in CME Group were worth $51,458,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of CME. Veritas Investment Partners UK Ltd. acquired a new stake in shares of CME Group in the fourth quarter worth approximately $367,000. Prudential PLC raised its stake in CME Group by 19.7% during the fourth quarter. Prudential PLC now owns 16,815 shares of the financial services provider’s stock worth $3,541,000 after purchasing an additional 2,766 shares during the period. Epoch Investment Partners Inc. boosted its holdings in shares of CME Group by 3.0% in the 4th quarter. Epoch Investment Partners Inc. now owns 95,493 shares of the financial services provider’s stock valued at $20,111,000 after purchasing an additional 2,774 shares during the last quarter. Vinva Investment Management Ltd boosted its holdings in shares of CME Group by 19.1% in the 4th quarter. Vinva Investment Management Ltd now owns 12,434 shares of the financial services provider’s stock valued at $2,624,000 after purchasing an additional 1,991 shares during the last quarter. Finally, Morningstar Investment Services LLC grew its stake in shares of CME Group by 123.7% during the 4th quarter. Morningstar Investment Services LLC now owns 6,564 shares of the financial services provider’s stock valued at $1,385,000 after buying an additional 3,630 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Stock Down 0.4 %

NASDAQ CME opened at $198.50 on Tuesday. The stock has a market cap of $71.47 billion, a PE ratio of 22.58, a P/E/G ratio of 5.27 and a beta of 0.52. The business has a 50 day moving average price of $209.39 and a two-hundred day moving average price of $210.51. CME Group Inc. has a fifty-two week low of $177.04 and a fifty-two week high of $223.80. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CMEGet Free Report) last announced its earnings results on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.44 by $0.06. CME Group had a net margin of 56.84% and a return on equity of 12.45%. The business had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.48 billion. During the same period in the prior year, the firm earned $2.42 earnings per share. The business’s quarterly revenue was up 3.2% compared to the same quarter last year. As a group, sell-side analysts predict that CME Group Inc. will post 9.72 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 25th. Stockholders of record on Friday, June 7th will be given a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.32%. The ex-dividend date is Friday, June 7th. CME Group’s payout ratio is 52.33%.

Insider Buying and Selling

In other CME Group news, Director Daniel R. Glickman sold 650 shares of the firm’s stock in a transaction that occurred on Thursday, June 6th. The stock was sold at an average price of $201.44, for a total transaction of $130,936.00. Following the completion of the sale, the director now owns 14,008 shares in the company, valued at approximately $2,821,771.52. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, Director Daniel R. Glickman sold 650 shares of the business’s stock in a transaction dated Thursday, June 6th. The stock was sold at an average price of $201.44, for a total value of $130,936.00. Following the completion of the sale, the director now directly owns 14,008 shares of the company’s stock, valued at $2,821,771.52. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Terrence A. Duffy sold 40,000 shares of the company’s stock in a transaction that occurred on Monday, April 29th. The shares were sold at an average price of $210.91, for a total value of $8,436,400.00. Following the sale, the chief executive officer now directly owns 67,455 shares in the company, valued at $14,226,934.05. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 51,290 shares of company stock worth $10,807,380. 0.30% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

CME has been the topic of several research reports. Rosenblatt Securities reaffirmed a “sell” rating and issued a $187.00 target price (up from $185.00) on shares of CME Group in a research report on Thursday, April 25th. Morgan Stanley raised their price objective on CME Group from $222.00 to $225.00 and gave the stock an “equal weight” rating in a report on Tuesday, April 9th. Keefe, Bruyette & Woods boosted their target price on CME Group from $222.00 to $226.00 and gave the stock a “market perform” rating in a report on Thursday, April 25th. Bank of America raised their price target on shares of CME Group from $209.00 to $216.00 and gave the company a “neutral” rating in a report on Thursday, April 25th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $210.00 price objective (down from $235.00) on shares of CME Group in a research note on Friday, April 5th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $217.80.

Check Out Our Latest Report on CME Group

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.